Patents by Inventor Avishai Mimran

Avishai Mimran has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150297693
    Abstract: The present invention relates to peptides capable of inhibiting cellular and immune stress responses in a eukaryotic cell. The invention provides compositions and methods for the treatment of human degenerative diseases and inflammation, utilizing these peptides.
    Type: Application
    Filed: June 30, 2015
    Publication date: October 22, 2015
    Applicant: YEDA RESEARCH AND DEVELOPMENT CO. LTD.
    Inventors: Johannes HERKEL, Irun R. COHEN, Varda ROTTER, Ansgar W. LOHSE, Neta EREZ, Avishai MIMRAN, Na'aman KAM
  • Publication number: 20140329758
    Abstract: The present invention relates to peptides capable of inhibiting cellular and immune stress responses in a eukaryotic cell. The invention provides compositions and methods for the treatment of human degenerative diseases and inflammation, utilizing these peptides.
    Type: Application
    Filed: July 27, 2014
    Publication date: November 6, 2014
    Inventors: JOHANNES KERKEL, IRUN R. COHEN, VARDA ROTTER, ANSGAR W. LOHSE, NETA EREZ, AVISHAI MIMRAN, NA'AMAN KAM
  • Patent number: 8790653
    Abstract: The present invention relates to peptides capable of inhibiting cellular and immune stress responses in a eukaryotic cell. The invention provides compositions and methods for the treatment of human degenerative diseases and inflammation, utilizing these peptides.
    Type: Grant
    Filed: November 1, 2011
    Date of Patent: July 29, 2014
    Assignee: Yeda Research and Development Co. Ltd.
    Inventors: Johannes Herkel, Irun R. Cohen, Varda Rotter, Ansgar W. Lohse, Neta Erez, Avishai Mimran, Na'aman Kam
  • Publication number: 20120171233
    Abstract: The present invention relates to peptides capable of inhibiting cellular and immune stress responses in a eukaryotic cell. The invention provides compositions and methods for the treatment of human degenerative diseases and inflammation, utilizing these peptides.
    Type: Application
    Filed: November 1, 2011
    Publication date: July 5, 2012
    Applicant: YEDA RESEARCH AND DEVELOPMENT CO. LTD. at The Weizmann Institute of Science
    Inventors: Johannes Herkel, Irun R. Cohen, Varda Rotter, Ansgar W. Lohse, Neta Erez, Avishai Mimran, Na'aman Kam
  • Patent number: 8067008
    Abstract: The present invention relates to peptides capable of inhibiting cellular and immune stress responses in a eukaryotic cell. The invention provides compositions and methods for the treatment of human degenerative diseases and inflammation, utilizing these peptides.
    Type: Grant
    Filed: August 23, 2005
    Date of Patent: November 29, 2011
    Assignee: YEDA Research and Development Co.
    Inventors: Johannes Herkel, Irun R. Cohen, Varda Rotter, Ansgar W. Lohse, Neta Erez, Avishai Mimran, Na'aman Kam
  • Publication number: 20080267983
    Abstract: The present invention relates to peptides capable of inhibiting cellular and immune stress responses in a eukaryotic cell. The invention provides compositions and methods for the treatment of human degenerative diseases and inflammation, utilizing peptides recognized by monoclonal anti-DNA antibodies, the peptides having anti-apoptotic and anti-inflammatory activity. The invention further provides antibody molecules and uses thereof for the isolation of such peptides.
    Type: Application
    Filed: August 23, 2005
    Publication date: October 30, 2008
    Applicant: YEDA RESEARCH AND DEVELOPMENT CO. LTD.
    Inventors: Johannes Herkel, Irun R. Cohen, Varda Rotter, Ansgar W. Lohse, Neta Erez, Avishai Mimran, Na'aman Kam
  • Publication number: 20070274949
    Abstract: Compositions comprising nucleic acids encoding the ? chain of IL-2 receptor (IL-2Ra, CD25), homologs and fragment thereof, are effective in the treatment and prevention of T cell mediated pathologies. Methods are provided for enhancing anti-ergotypic T cell activity in a subject in need thereof, and for treating or preventing T cell mediated pathologies, such as autoimmune disease, inflammatory diseases and graft rejection.
    Type: Application
    Filed: June 8, 2007
    Publication date: November 29, 2007
    Applicant: Yeda Research and Development Co. Ltd. at the Weizmann Institute of Science
    Inventors: Irun Cohen, Avishai Mimran, Francisco Quintana, Felix Mor, Pnina Carmi
  • Publication number: 20070238099
    Abstract: A method of typing a variable region of a specific variant of an antigen receptor chain is disclosed.
    Type: Application
    Filed: October 25, 2004
    Publication date: October 11, 2007
    Inventors: Irun Cohen, Daniel Douek, Avishai Mimran, Pnina Carmi, Francisco Quintana